Personalizing Treatment in Type 2 Diabetes: A Self-Monitoring of Blood Glucose Inclusive Innovative Approach

被引:18
作者
Ceriello, Antonio [1 ,2 ]
Gallo, Marco [3 ]
Armentano, Vincenzo [4 ]
Perriello, Gabriele [5 ]
Gentile, Sandro [6 ]
De Micheli, Alberto [7 ]
机构
[1] Inst Biomed Invest August Pi & Sunyer, Barcelona, Spain
[2] Ctr Biomed Res Diabet & Associated Metab Dis, Barcelona, Spain
[3] Azienda Univ Hosp, Univ Hosp Molinette S Giovanni Battista Turin, Turin, Italy
[4] Azienda Local Hlth Naples 1, Unit Diabetol & Metab Dis Complex, Naples, Italy
[5] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy
[6] Univ Naples 2, Dept Clin & Expt Med, Naples, Italy
[7] Liguria Reg Hlth Agcy, Genoa, Italy
关键词
GLYCEMIC CONTROL; MANAGEMENT; MELLITUS; ASSOCIATION; THERAPY; DRUGS; ADJUSTMENT; STATEMENT; OUTCOMES; TARGETS;
D O I
10.1089/dia.2011.0233
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
A strong correlation exists between improved blood glucose control, obtained from the earliest stages of diabetes, and the prevention of complications. However, tight glycometabolic control does not always translate into an advantage for every patient. Because the characteristics of individual patients play an important role in diabetes care, there is a need to develop personalized action plans. This article suggests tailored therapeutic algorithms for some of the commonest type 2 diabetes phenotypes, taking into consideration age, body mass index, presence of micro- and macrovascular complications, hypoglycemia risk, and the co-existence of chronic renal failure. Particular emphasis is placed on exploiting information supplied through the rational use of self-monitoring of blood glucose as a tool for optimizing diabetes management, according to the prevalence of fasting/preprandial or postprandial hyperglycemia.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 46 条
[1]
Guidelines Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance [J].
Adler, Amanda I. ;
Shaw, Elizabeth J. ;
Stokes, Tim ;
Ruiz, Francis .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
[2]
[Anonymous], DIAB TREATM ALG DIAB
[3]
[Anonymous], COMP EFFECTIVENESS R
[4]
[Anonymous], 2010, HEALTH TECHNOL ASSES
[5]
[Anonymous], Global guideline for type 2 diabetes
[6]
[Anonymous], ITALIAN NATL GUIDELI
[7]
[Anonymous], 2011, WORKING GROUP PERSON
[8]
Associazione Medici Diabetologi (AMD)/Societa Italiana di Diabetologia (SID), 2018, STAND IT CUR DIAB ME
[9]
Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations [J].
Bennett, Wendy L. ;
Maruthur, Nisa M. ;
Singh, Sonal ;
Segal, Jodi B. ;
Wilson, Lisa M. ;
Chatterjee, Ranee ;
Marinopoulos, Spyridon S. ;
Puhan, Milo A. ;
Ranasinghe, Padmini ;
Block, Lauren ;
Nicholson, Wanda K. ;
Hutfless, Susan ;
Bass, Eric B. ;
Bolen, Shari .
ANNALS OF INTERNAL MEDICINE, 2011, 154 (09) :602-613
[10]
Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin [J].
Bonomo, Katia ;
De Salve, Alessandro ;
Fiora, Elisa ;
Mularoni, Elena ;
Massucco, Paola ;
Poy, Paolo ;
Pomero, Alice ;
Cavalot, Franco ;
Anfossi, Giovanni ;
Trovati, Mariella .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (02) :246-251